-
1.
Lookstein RA, et al. Drug-coated balloons for dysfunctional dialysis arteriovenous fistulas. N Engl J Med 2020; 383:733–742. doi: 10.1056/NEJMoa1914617
-
2.
Katsanos K, et al. Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc 2018; 7:e011245. doi: 10.1161/JAHA.118.011245
-
3.
24 Hour Summary of the Circulatory System Devices Panel Meeting: Paclitaxel-Coated DCB and DES Late Mortality: General Issues Panel, June 19–20, 2019. Bethesda, MD: U.S. Food and Drug Administration, 2019. https://www.fda.gov/media/128246/download
-
4.
Dinh K, et al. Mortality after paclitaxel-coated device use in dialysis access: a systematic review and meta-analysis. J Endovasc Ther 2019; 26:600–612. doi: 10.1177/1526602819872154
-
5.
Trerotola SO, et al. Drug coated balloon angioplasty in failing AV fistulas: a randomized controlled trial. Clin J Am Soc Nephrol 2018; 13:1215–1224. doi: 10.2215/CJN.14231217
-
6.
McLennan G Stent and stent-graft use in arteriovenous dialysis access. Semin Intervent Radiol 2016; 33:10–14. doi: 10.1055/s-0036-1571806
-
7.
e-PTFE covered stent demonstrates “significantly better” target lesion primary patency compared to angioplasty out to 12 months in haemodialysis AV fistulae. Vascular News September 18, 2019; 2727. https://vascularnews.com/e-ptfe-covered-stent-demonstrates-significantly-better-target-lesion-primary-patency-compared-to-angioplasty-out-to-12-months-in-hemodialysis-arteriovenous-fistulae/
Study Strengthens Case for Drug-Coated Balloons for Dysfunctional AV Fistulas
Search for other papers by Ruth Jessen Hickman in
Current site
Google Scholar
PubMed
© 2021 American Society of Nephrology | All Rights Reserved
Powered by: PubFactory